Literature DB >> 20011197

The pathologist's role in rectal cancer patient assessments.

Joseph E Willis1.   

Abstract

Since Cuthbert Dukes fundamental work linking cancer stage to prognosis, the pathologist has had an ever-expanding role in the multidisciplinary management of rectal cancer. Gross dissection techniques and histologic evaluation are reviewed. The evolving tumor size, node status, metastasis classification (TNM) staging system is outlined. The pathologist's critical role in correctly assessing circumferential margins and establishing resection adequacy and staging accuracy via lymph node assessment is emphasized.

Entities:  

Keywords:  Rectal cancer; metastasis (TNM) classification; node status; pathological evaluation; total mesorectal excision; tumor size

Year:  2007        PMID: 20011197      PMCID: PMC2789503          DOI: 10.1055/s-2007-984860

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  83 in total

1.  Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage.

Authors:  N S Goldstein; A Soman; J Sacksner
Journal:  Am J Clin Pathol       Date:  1999-03       Impact factor: 2.493

Review 2.  Pathology report in colon cancer: what is prognostically important?

Authors:  C C Compton
Journal:  Dig Dis       Date:  1999       Impact factor: 2.404

3.  A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.

Authors:  Hakjung Kang; Jessica B O'Connell; Melinda A Maggard; Jonathan Sack; Clifford Y Ko
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

4.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

5.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

6.  Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients.

Authors:  P J Sitzler; F Seow-Choen; Y H Ho; A P Leong
Journal:  Dis Colon Rectum       Date:  1997-12       Impact factor: 4.585

7.  Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.

Authors:  Ugur Berberoglu
Journal:  Hepatogastroenterology       Date:  2004 Nov-Dec

8.  Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly.

Authors:  Ruwan E Wijesuriya; Kemal I Deen; Janaki Hewavisenthi; Jayantha Balawardana; Mahendra Perera
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

9.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

10.  Endoscopically removed malignant colorectal polyps: clinicopathologic correlations.

Authors:  H S Cooper; L M Deppisch; W K Gourley; E I Kahn; R Lev; P N Manley; R R Pascal; A H Qizilbash; R R Rickert; J F Silverman
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

View more
  1 in total

1.  Postoperative radio-chemotherapy for rectal cancer: A retrospective analysis from a tertiary referral hospital.

Authors:  Ewa Wasilewska-Teśluk; Monika Rucińska; Karolina Osowiecka; Iwona Ryniewicz-Zander; Beata Czeremszyńska; Krzysztof Gliński; Lucyna Kępka
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.